Drug intelligence / Profile preview

metronidazole benzoate

Development stage
Approved
Modality
Small Molecules
Administration
Oral
01

Overview

Metronidazole benzoate is a benzoate ester derivative of metronidazole, formed by the condensation of benzoic acid with the hydroxy group of metronidazole. It appears as a crystalline, white or slightly yellowish powder and is less bitter than standard metronidazole, making it suitable for oral suspensions, especially in pediatric and veterinary use[1][5]. Metronidazole (the active moiety) is an antibiotic and antiprotozoal agent belonging to the nitroimidazole class. Its mechanism involves diffusion into anaerobic bacteria and protozoa where it is reduced to a nitroso free radical that disrupts DNA structure, leading to cell death[3]. Metronidazole benzoate is used primarily for treating bacterial infections (especially anaerobic bacteria) and intestinal parasites such as amoebiasis and giardiasis[1][4]. It may also be used in veterinary medicine when compounded due to its improved palatability over standard formulations[5].

Other names
metronidazole benzoate
02

Targets

Neuraminidase

Beyond the preview

Go deeper on metronidazole benzoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metronidazole benzoate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call